- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
- 10-K Annual report
- 4.3 Exhibit 4.3_DESCRIPTION of Equity
- 19.1 Exhibit 19.1 Mesa Laboratories Inc. Insider Trading Policy
- 21.1 Exhibit 21.1 Subsidiaries
- 23.1 Exhibit 23.1
- 23.2 Exhibit 23.2_PLANTE Moran
- 31.1 Exhibit 31.1
- 31.2 Exhibit 31.2
- 32.1 Exhibit 32.1
- 32.2 Exhibit 32.2
- 97.1 Exhibit 97.1 Mesa Laboratories Inc. Clawback Policy
- Download Excel data file
- View Excel data file
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements (No. 333-274263, 333-259154, and 333-206551) on Form S-8 and the Registration Statement (No. 333-264137) on Form S-3 of Mesa Laboratories, Inc. of our reports dated June 28, 2024, relating to the consolidated financial statements and the effectiveness of internal control over financial reporting (on which our report expresses an adverse opinion on the effectiveness of the Company's internal control over financial reporting because of material weaknesses), of Mesa Laboratories, Inc., appearing in this in this Annual Report on Form 10-K of Mesa Laboratories, Inc. for the year ended March 31, 2024.
/s/ RSM US LLP
Los Angeles, California